This article was originally posted here
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Amneal Pharmaceuticals, Inc. (AMRX) : This company that develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products has seen the Zacks Consensus Estimate for its current year earnings increasing 14% over the last 60 days.
AMNEAL PHARMACEUTICALS, INC. Price and Consensus
MACOM Technology Solutions Holdings, Inc. (MTSI) : This company that designs and manufactures analog radio frequency has seen the Zacks Consensus Estimate for its current year earnings increasing 70% over the last 60 days.
MACOM Technology Solutions Holdings, Inc. Price and Consensus
Pluralsight, Inc. (PS) : This company that provides a technology skill development solution has seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Pluralsight, Inc. Price and Consensus
The J. M. Smucker Company (SJM) : This company that manufactures and markets branded food and beverage products has seen the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
The J. M. Smucker Company Price and Consensus
Aerpio Pharmaceuticals, Inc. (ARPO) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.2% over the last 60 days.
Aerpio Pharmaceuticals, Inc. Price and Consensus
Editor's Note:
[BREAKING] #1 Micro-Cap Stock to Buy Today
Dear Fellow Investor,
Big Pharma loves to buy small biotech's right after the market drops.
When the market dropped 19% in the fourth quarter of 2018, Ex-Wall Street CEO Dylan Jovine picked 3 biotech stocks ripe for a takeover.
On October 1st, 2018, he recommended Tesaro… 63 days later it was taken over for an easy 91% profit…
On October 19, 2018 he recommended Pacific Biosciences… 4 days later it was taken over for a quick 72% gain…
On January 4, 2019 he recommended Loxo Oncology… 3 days later it was taken over for a fast 71% gain…
Well guess what? The Coronavirus market drop has given Big Pharma its first takeover target of 2020.
In this special letter, you'll learn why Dylan thinks now is the best time to make money with this tiny stock.
You'll discover:
- Why Big Pharma firms Allergan, Celgene and others have invested over $1 billion into this tiny biotech.
- Why President Trump thinks this biotech's breakthrough is a matter of national security.
- How a takeover could make you $41,250 in profits any day now.
That's because in this letter, we'll show you how get into this company right now – before it's too late!
You don't want to miss this.
Read this urgent letter now >>>
